Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Schwendel, Frank Richard, H. Langreck, O. Kaufmann, Hermann Lage, K. Winzer, I. Petersen, Manfred Dietel (1998)
Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.British Journal of Cancer, 78
(2003)
World Health Organization Classification of Tumors: Pathology and Genetics: Tumors of the Breast and Female Genital Organs
G. Spizzo, G. Gastl, P. Obrist, P. Went, S. Dirnhofer, S. Bischoff, M. Mirlacher, G. Sauter, R. Simon, Shanna Stopatschinskaya, P. Haas, R. Bart, O. Köchli, H. Spichtin, R. Maurer, U. Metzger, B. Castelberg, M. Zuber, Friedrich Mross, H. Dietrich (2004)
High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast CancerBreast Cancer Research and Treatment, 86
D. Euhus, A. Maitra, I. Wistuba, A. Alberts, J. Albores–Saavedra, A. Gazdar (1999)
Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.The Journal of surgical research, 83 1
S. Seitz, K. Poppe, J. Fischer, A. Nothnagel, L. Estévéz‐Schwarz, W. Haensch, P. Schlag, S. Scherneck (2001)
Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parametersThe Journal of Pathology, 194
S. Aulmann, M. Bentz, H. Sinn (2002)
C-myc oncogene amplification in ductal carcinoma in situ of the breastBreast Cancer Research and Treatment, 74
G. Hudelist, Margit Pacher-zavisin, C. Singer, T. Holper, E. Kubista, M. Schreiber, M. Manavi, M. Bilban, K. Czerwenka (2004)
Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast TissueBreast Cancer Research and Treatment, 86
Michael Gonzalez, S. Pinder, G. Callagy, S. Vowler, L. Morris, K. Bird, J. Bell, R. Laskey, N. Coleman (2003)
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 23
B. Bonsing, P. Devilee, A. Cleton-Jansen, N. Kuipers-Dijkshoorn, G. Fleuren, C. Cornelisse (1993)
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.Cancer research, 53 16
A. Somasiri, Julie Nielsen, N. Makretsov, Marcia McCoy, Leah Prentice, C. Gilks, Stephen Chia, K. Gelmon, David Kershaw, David Huntsman, K. McNagny, C. Roskelley (2004)
Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer ProgressionCancer Research, 64
U. Woelfle, G. Sauter, Sonja Santjer, R. Brakenhoff, K. Pantel (2004)
Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast CancerClinical Cancer Research, 10
Yasushi Nakamura, H. Yasuoka, M. Tsujimoto, Qifeng Yang, S. Imabun, M. Nakahara, K. Nakao, Misa Nakamura, I. Mori, K. Kakudo (2003)
Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 2
R. Camp, E. Rimm, D. Rimm (1999)
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinomaCancer, 86
Sorbello (2003)
Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer.Int J Biol Markers, 18
Lenora Loo, Carl Ton, Y. Wang, D. Grove, Heather Bouzek, N. Vartanian, Ming-Gang Lin, Xiaopu Yuan, T. Lawton, J. Daling, K. Malone, Christopher Li, L. Hsu, Peggy Porter (2008)
Differential patterns of allelic loss in estrogen receptor‐positive infiltrating lobular and ductal breast cancerGenes, 47
E. Honrado, J. Benítez, J. Palacios (2005)
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implicationsModern Pathology, 18
(2004)
Genome-wide geneexpression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis
R. Fonseca, A. Tomás, S. André, J. Soares (2006)
Evaluation of ERBB2 Gene Status and Chromosome 17 Anomalies in Male Breast CancerThe American Journal of Surgical Pathology, 30
S. Al-sam, S. Jader (2005)
Invasive breast carcinoma
S. Aulmann, N. Adler, J. Rom, B. Helmchen, P. Schirmacher, H. Sinn (2006)
c-myc Amplifications in primary breast carcinomas and their local recurrencesJournal of Clinical Pathology, 59
A. Pinto, L. Roque, R. Rodrigues, S. André, J. Soares (2006)
Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisationJournal of Clinical Pathology, 59
N. Linder, J. Lundin, J. Isola, M. Lundin, K. Raivio, H. Joensuu (2005)
Down-Regulated Xanthine Oxidoreductase Is a Feature of Aggressive Breast CancerClinical Cancer Research, 11
Alonso Martínez, R. Walker, J. Shaw, S. Dearing, E. Maher, F. Latif (2001)
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological featuresMolecular Pathology, 54
Y. Umekita, Hiroki Yoshida (2003)
Expression of maspin is up‐regulated during the progression of mammary ductal carcinomaHistopathology, 42
V. Sorbello, L. Fuso, C. Sfiligoi, C. Scafoglio, R. Ponzone, N. Biglia, A. Weisz, P. Sismondi, M. Bortoli (2003)
Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer.The International journal of biological markers, 18 2
M. Pierotti, A. Greco (2006)
Oncogenic rearrangements of the NTRK1/NGF receptor.Cancer letters, 232 1
M. Hori, J. Shimazaki, S. Inagawa, M. Itabashi, M. Hori (2000)
Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvementPathology International, 50
Monika Hampl, Jürgen Hampl, Gilfe Reiss, Gabriele Schackert, Hans-Detlev Saeger, H. Schackert (1999)
Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 6
M. Aubele, M. Cummings, A. Mattis, H. Zitzelsberger, A. Walch, M. Kremer, H. Höfler, M. Werner (2000)
Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.Diagnostic molecular pathology : the American journal of surgical pathology, part B, 9 1
PS Larson, A. Morenas, S. Cerda, SR Bennett, L. Cupples, CL Rosenberg (2006)
Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursorsThe Journal of Pathology, 209
J. Climent, J. Martinez-Climent, D. Blesa, M. Garcia-Barchino, R. Sáez, D. Sánchez-Izquierdo, P. Azagra, A. Lluch, J. Garcia-conde (2002)
Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 12
A. Maitra, I. Wistuba, C. Washington, A. Virmani, R. Ashfaq, S. Milchgrub, A. Gazdar, J. Minna (2001)
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.The American journal of pathology, 159 1
S. Bandyopadhyay, S. Pai, S. Hirota, S. Hosobe, T. Tsukada, Kunio Miura, Y. Takano, Ken Saito, T. Commes, D. Piquemal, M. Watabe, S. Gross, Ying Wang, J. Huggenvik, K. Watabe (2004)
PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast CancerCancer Research, 64
Toshihiko Nishidate, T. Katagiri, Meng‐Lay Lin, Y. Mano, Y. Miki, F. Kasumi, M. Yoshimoto, T. Tsunoda, K. Hirata, Yusuke Nakamura (2004)
Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.International journal of oncology, 25 4
K. Driouch, F. Dorion-Bonnet, M. Briffod, M. Champème, M. Longy, R. Lidereau (1997)
Loss of heterozygosity on chromosome arm 16q in breast cancer metastasesGenes, 19
B. Orsetti, Mélanie Nugoli, N. Cervera, L. Lasorsa, P. Chuchana, C. Rougé, L. Ursule, Catherine Nguyen, F. Bibeau, C. Rodríguez, C. Theillet (2006)
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1qBritish Journal of Cancer, 95
H. Tsuda, S. Hirohashi (1995)
Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.Cancer research, 55 15
S. Mehta, Kent Christopherson, P. Bhat-Nakshatri, Robert Goulet, H. Broxmeyer, L. Kopelovich, H. Nakshatri (2007)
Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasionOncogene, 26
E. Janssen, J. Baak, M. Guervós, P. Diest, M. Jiwa, M. Hermsen (2003)
In lymph node‐negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptorThe Journal of Pathology, 201
K. Marsh, Jm Varley (1998)
Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.British Journal of Cancer, 77
B. Davidson, R. Reich, P. Lazarovici, V. Flørenes, S. Nielsen, J. Nesland (2004)
Altered Expression and Activation of the Nerve Growth Factor Receptors TrkA and p75 Provide the First Evidence of Tumor Progression to Effusion in Breast CarcinomaBreast Cancer Research and Treatment, 83
A. Castells, J. Gusella, V. Ramesh, A. Rustgi (2000)
A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.Cancer research, 60 11
Xiaoqi Lin, S. Finkelstein, B. Zhu, J. Silverman (2008)
Molecular analysis of multifocal papillary thyroid carcinoma.Journal of molecular endocrinology, 41 4
D. Radford, N. Phillips, K. Fair, J. Ritter, M. Holt, H. Donis-Keller (1995)
Allelic loss and the progression of breast cancer.Cancer research, 55 22
P. Achary, Hui Zhao, Z. Fan, Swarna Gogineni, V. Pulijaal, L. Herbst, P. Mahadevia, Joan Jones, H. Klinger, B. Vikram (2003)
A candidate metastasis-associated DNA marker for ductal mammary carcinomaBreast Cancer Research, 5
S. Ikeda, Toshikatsu Shibata, Y. Eishi, T. Takizawa, M. Koike (2003)
Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining methodPathology International, 53
A. Morikawa, T. Williams, L. Dirix, C. Colpaert, M. Goodman, R. Lyles, D. Zhong, W. Zhou (2005)
Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancerBreast Cancer Research, 7
T. Nishizaki, S. Devries, K. Chew, W. Goodson, B. Ljung, A. Thor, F. Waldman (1997)
Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridizationGenes, 19
Ling Chen, W. Kurisu, B. Ljung, Eric Goldman, Dan Moore, Helene Smith (1992)
Heterogeneity for allelic loss in human breast cancer.Journal of the National Cancer Institute, 84 7
C. Pizzi, L. Panico, L. Marchis, P. Mastranzo, M. Maio, C. D'amico, G. Limite, G. Pettinato, S. Cocozza, A. Bianco, A. Contegiacomo (2002)
p53 Expression is Decreased in Primary Breast Carcinomas with Microsatellite InstabilityBreast Cancer Research and Treatment, 73
P. Depowski, Seth Rosenthal, T. Brien, S. Stylos, Rebecca Johnson, J. Ross (2000)
Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome VariablesModern Pathology, 13
E. Rakha, D. Rehim, S. Pinder, S. Lewis, I. Ellis (2005)
E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significanceHistopathology, 46
E. Imyanitov, E. Suspitsin, M. Grigoriev, A. Togo, E. Kuligina, E. Belogubova, K. Pozharisski, Elena Turkevich, Carmen Rodriquez, C. Cornelisse, K. Hanson, C. Theillet (2002)
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomasInternational Journal of Cancer, 100
RESEARCH ARTICLE Significance of Loss of Heterozygosity in Predicting Axillary Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast Xiaoqi Lin, MD, PhD,* Bing Zhu, MD, PhD,* Sydney D. Finkelstein, MD,w Reda S. Saad, MD,z Andrea Snitchler, DO,y and Jan F. Silverman, MDy INTRODUCTION Abstract: Invasive ductal carcinoma (IDC) of breast metastatic Invasive ductal carcinoma (IDC) of the breast is a to axillary lymph node (ALN) is a critical factor in determining malignancy characterized by accumulation of multiple stage and is a strong predictor of disease prognosis and survival. genetic alterations that control cell cycle, invasion, We studied ALN metastasis using a combined histopathologic/ 1,2 metastasis, etc, although the molecular basis of IDC molecular approach to gain insights into the pathobiology tumorigenesis and metastasis is still not completely implications. Fourteen patients with IDC with positive ALN understood. IDC staging remains the strongest clinically and 19 with negative ALN were retrieved. Analysis of 17 used predictor of disease aggressiveness and survival. The polymorphic microsatellite repeat markers targeting 1p34-36, well-accepted prognostic factors related to breast cancer 3p24-26, 5q23, 9p21, 10q23, 17p13, 17q12, 17q21, 21q22, and are lymph node status, tumor size, histopathologic 22q13 was carried out in DNA isolated from
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Mar 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.